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ABSTRACT 
The prospect of nanotechnology is exciting not only for its promise to miniaturize 
complex devices, but perhaps even more so because of the unconventional characteristics 
exhibited by many nano-sized materials.  Zinc oxide (ZnO) nanoparticles are being 
explored for applications ranging from sunscreens, to advanced textiles, to self-charging 
electronic devices.  As their industrial production accelerates, attention must be given to 
their potential to interact with organisms and ecosystems in unexpected ways.  The goal 
of this work was to assess the interaction of ZnO nanoparticles with immune cell cultures 
consisting of various cell types to identify the mechanisms underlying ZnO nanotoxicity.  
Using immunofluorescent staining and flow cytometry, the effect of ZnO nanoparticles 
on various murine immune cell types was studied.  After preliminary viability testing 
using AnnexinV and Live/Dead staining, ZnO were shown to be significantly more toxic 
than titanium dioxide nanoparticles and gold nanoparticles, and they began inducing 
apoptosis within eight hours in culture at 50 µg/ml.  To evaluate the role of particle 
uptake into cells and explore surface modification techniques applicable to ZnO 
nanoparticles, a coating of polyethylene glycol (PEG) was conjugated to the nanoparticle 
surface through hydrogen-bonding, but it did not attenuate nanotoxicity.  Upon further 
characterization, the PEGylated ZnO surface was found to have adsorbed serum proteins, 
possibly due to the non-uniform molecular architecture of PEG.  Protein adsorption may 
have therefore been responsible for permitting nanoparticle internalization.  As an 
alternative, ZnO nanoparticle-treated cells were treated with extracellular inhibitors of 
suspected ROS and cation mechanisms, and the antioxidant enzyme catalase was found 
to significantly reduce ZnO nanotoxicity, implicating a role of extracellular H2O2.  Using 
xiv  
an intracellular reactive oxygen detection dye, 2’,7’-di-chlorofluorescein diacetate, ZnO 
nanoparticles were shown to induce an “oxidative burst” within the cell, which was not 
reduced by catalase.  Taken together, catalase inhibition studies reveal that ZnO 
nanotoxicity within splenocyte cultures may act largely through apoptotic signaling 
between cell types.  Future strategies to engineer safe nano ZnO may therefore include 
catalase-mimicking components, such as nano platinum.  
    1 
1. BACKGROUND 
 
1.1. A Need to Study Nanotoxicity 
 
As the nanotechnology industry promises to accelerate over the coming decades, 
manufactured nanoparticles may pose serious health threats (Nowack & Bucheli, 2007; 
Auffan et al 2009).  It is estimated that the amount of manufactured nanoparticles will 
rise sharply from 2,300 tons produced today to 58,000 tons by 2020 (Wang et al 2009).  
Zinc Oxide (ZnO) nanoparticles in particular have significant potential for a variety of 
applications.  Currently nano-sized ZnO is being used in sunscreens at concentrations of 
5-10% (weight by volume), due to its ability to absorb UV-radiation.  The potential for 
ZnO nanoparticles extends far beyond cosmetics, however.  Some textile manufacturers 
are exploring methods of infusing ZnO nanoparticles into fabrics such as cotton and wool 
as a protective shield against UV-radiation to protect from fading.  However, 
nanoparticles can come loose during laundering (Becheri et al 2008) and subsequently get 
into drainwater, inevitably dispersing into the environment. They are being explored as 
key materials for photoconductivity in electronics such as cell phones and ipods (Lin et al 
2009, Jin et al 2008, Seow et al 2009).  The unique ability of ZnO nanoparticles to absorb 
electromagnetic waves opens the door for the development of a wide array of exciting 
technologies, but understanding the long term effects of ZnO nanoparticles on cells and 
organisms, especially as they relate to the immune system, is critical.  The accumulation 
of ZnO nanoparticles and their associated nanotoxicity in an ecosystem would be 
expected to have a major impact on ecosystems. In the proposed study we strive for a 
mechanistic understanding of the effect of ZnO nanoparticles on the immune response.  
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We will also test ways to minimize and possibly eliminate adverse effects through 
surface modifications and antioxidants, depending on the mechanism of action. 
It is estimated that approximately 100 uL of ZnO nanoparticles is applied to the 
face in each use, which equates to 5-10 mg of skin exposure for every application.  
Although generally skin adequately prevents many nanoparticles from entering the body, 
they can be easily ingested through inhalation and subsequently dispersed throughout 
various compartments (Long et al 2006, Gojova et al 2007, Pinnell et al 2000).  In mice, 
several studies have indicated increased levels of vascular plaque after exposure to 
single-walled carbon nanotubes (Jacobsen et al 2009).  Recent studies have shown that 
nanoparticles can cross the blood-brain barrier and exhibit effects on the central nervous 
system (Long et al 2006).  When administered dermally, NPs have been known to 
localize to regional lymph nodes (Cross et al 2007).  Once inside the cell, studies have 
suggested that ZnO nanoparticles may induce adverse effects such as enhanced 
expression of pro-inflammatory cytokines, the generation of reactive oxygen species 
(ROS), and DNA strand breaks (Rothen-Rutishauser et al 2007).   
Although only small lipophilic molecules are able to easily penetrate the skin 
passively, some recent studies have indicated that the mechanisms of entry are different 
between chemicals and particles, and nanoparticles might enter the body 
transcutaneously.  One study (Baroli et al 2007) testing the penetration of metallic 
nanoparticles (Fe and γ-Fe2O3) through human skin concluded that rigid nanoparticles 
less than 10 nm in size were capable of passively entering through the stratum corneum 
(SC).  These particles passed through the SC lipidic matrix and hair follicle orifices and 
eventually localized as deep as the viable epidermis.  This study demonstrated also that 
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nanoparticle aggregates of up to several micrometers could penetrate the SC (Baroli et al 
2007).  Another study reported that nanoparticles (0.5-1um) reached the epidermis and 
sometimes the dermis when mechanically rubbed into the skin (Tinkle et al 2003), which 
would occur with most locally applied medications, sunscreens and cosmetics.  The 
review of Newman, Stotland, and Ellis (2009) noted that real-life scenarios testing skin 
penetration of ZnO nanoparticles, including tests on sunburned skin and under UV 
exposure, are lacking.  The potential for nanoparticles to enter the body cutaneously 
warrants further investigation into possible toxicity. 
The systematic study of the effects of exposure of different cell types (i.e. 
immune cells, skin cells, lung cells) to different size of same chemistry nanoparticles and 
same size, different chemistry nanoparticles followed by animal studies of relevant 
exposure is still lacking.  In response to this absence, the US National Academy of 
Sciences (NAS) stated that toxicological testing should shift its focus from an 
observational science to a predictive one, which utilizes mechanisms of cellular entry and 
toxicity to guide the judicious use of in-vivo studies (National Research Council 2007).  
Exposure concentrations abnormally high – that are not going to be encountered even at 
chronic exposure levels, may provide misleading information, and naturally the same is 
true for very low concentrations that do not account for chronic environmental exposure. 
It is known that ZnO nanoparticles can cross the cell membrane, but the 
mechanism of internalization is currently under debate (Rothen-Rutishauser et al 2007, 
Wang et al 2009, Gojova et al 2007, Heinlaan et al 2008). Even non-phagocytic cells 
such as red blood cells have been shown to internalize nanoparticles.  Postulated 
mechanisms of internalization include endocytosis, membrane fluidity, passing through 
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channels, or through adhesive interactions (Rothen-Rutishauser et al 2007).  TEM 
methods have recently indicated that gold nanoparticles could enter the cell membrane as 
aggregates (Wang et al 2009).  In some instances, human aortic endothelial cells 
(HAECs) treated with ZnO nanoparticles exhibited discontinuities in the cell membrane 
under thin-section TEM images (Gojova et al 2007).  It has further been observed that 
metal oxide nanoparticles do not necessarily have to enter the cells to cause toxicity 
(Heinlaan et al 2008).   
Gojova reported that acute exposure (50 ug/mL) to ZnO nanoparticles resulted in 
50% death in human aortic endothelial cells after just 4 hours of incubation and 20% cell 
death at 10 ug/mL.  At lower concentrations, no cell loss was observed.  Rodent 
fibroblasts, used in a study by Brunner et al (2006), died upon exposure to 30 nm ZnO 
nanoparticles at concentrations higher than 15 ug/mL.  Cell functionality, assessed by 
DNA Hoechst assay, was significantly reduced at concentrations as low as 3.75 ug/mL 
over a period of 3 days. 
ZnO nanoparticles (<50nm) have been shown to elicit an inflammatory reaction in 
HAECs in a concentration-dependent manner, as shown by increasing levels of 
inflammatory markers ICAM-1, IL-8, and MCP-1 mRNA in a dose dependent fashion 
(Gojova et al 2007).  Cytokine mRNA (Mip-2, Mcp-I, and Il-6) expression has also been 
shown to increase with exposure to 1 nm diameter single-walled carbon nanotubes and 2 
nm gold nanoparticles in mice in-vivo (Jacobsen et al 2009).  In addition, these results 
show that carbon nanotubes elicit a larger and more immediate increase in mRNA levels 
than do gold nanoparticles in-vivo in mouse lung tissue.   
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In-vitro studies on gold nanoparticles show no significant effect on macrophage 
phagocytosis (Knight et al 2007).  Cytotoxic effects of 15 nm gold nanoparticles at 2.5 
ug/cm2 were studied by Knight et al (2007) who reported that lung fibroblasts were not 
adversely effected by any tested concentration, while lymphocytes and murine 
macrophages showed significantly inhibited growth at 75% and 90% relative survival, 
respectively.  Vallhov et al (2006) reported that gold nanoparticles were “highly unlikely 
to initiate a danger signal to the immune system through the dendritic cells.” 
Jacobsen et al (2009) found that inflammation may directly correlate with the 
specific surface area of the gold nanoparticles and carbon nanotubes.  Although it is 
generally acknowledged that the inflammatory and cytotoxic effects of nanoparticles are 
dependent on their concentration (Brunner et al 2006), specific surface area, and 
composition, among other parameters (Wang et al 2009, Gojova et al 2007, Jacobsen et al 
2009), the individual influences of each parameter have not been fully identified or 
understood.  What such nanotoxicity means at a systemic level is also not known.  We 
predict that such nanotoxicity would impair the immune system of hosts, affect protective 
immune responses to pathogens and therefore could even perturb ecosystems over time. 
The immune system is an enormously complex mechanism which responds and 
adapts to the environment, maintaining constant protection against viruses, bacteria and 
other pathogens.  The ability of the immune system to distinguish between friend and foe 
is the product of a long co-evolution with a variety of organisms.  The emergence of new 
molecular techniques and information has promoted a growth of interest in the cross-
disciplinary field known as ecological immunology (Schulenburg et al 2009).  This new 
sub discipline concerns itself with the ecosystem's evolutionary impact on the immune 
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system.  The delicate interdependence between immunology and ecology raises the 
concern for the impact of an impaired immune system on its ecosystem.  A healthy 
immune system, which optimizes resources by permitting symbiots and attacks 
pathogens, maintains an equilibrium with surrounding organisms.  Therefore any 
perturbation in its activity, whether unnecessarily stimulated or suppressed, is likely to 
upset this balance and impact the ecosystem.  When evaluating potential hazards to an 
ecosystem, it is therefore advantageous to take an immunological approach. 
 
1.2. Potential ZnO Nanotoxicity Pathways 
Several studies indicate a possible toxic role of dissociated Zn2+ cations from ZnO 
nanoparticles (Brunner et al 2006; Kasemets et al 2009).  Soluble Zn2+ from ZnO 
nanoparticles was shown to induce toxicity in crustaceans Daphnia magna and 
Thamnocephalus platyurus and bacteria Vibrio fischeri (Heinlaan et al 2008).  Zinc has 
been known to exhibit toxic properties for over a decade and has been attributed with 
causing the flu-like symptoms associated with metal fume fever (MFF) in welders.  An 
upregulation of several inflammatory cytokines characteristic of MFF, including tumor 
necrosis factor (TNF)-α, MIP-2, and interleukin (IL)-6, has been recorded in cultures 
exposed to ZNPs (Gojova et al 2007).  The dissociation of ZnO has been shown to 
disrupt cellular zinc homeostasis and subsequently induces cell death (Xia et al 2008). 
The electronic/ionic transfer that occurs as part of redox cycling during the dissociation 
reaction has been proposed as a likely cause of toxicity by producing ROS either within 
the nanoparticles’ lattice or by release into culture media (Auffan et al 2009).  If released, 
Zn2+ could rapidly bind to cell membranes as suggested by its high affinity for 
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phospholipids, or it may interact with membrane-bound enzymes through reactions with 
sulphydryl groups to form stable mercaptides (Marin et al 2000). Whether Zn2+ damages 
cells before or after being taken up into the cell is unclear (Brunner et al 2006).   
It is also possible that Zn2+ may induce intracellular ROS.  Invesitigations of the 
role of Zn2+ in neurotoxicity have suggested a similarity to toxicity via rapid entry of 
Ca2+, whereby the mitochondrial membrane potential is compromised, triggering ROS 
release and pro-apoptotic factors (Marin et al 2000, Jiang et al 2001, Xia et al 2009).  In a 
study of the relative potency between Ca2+ and Zn2+, it was shown that 10 nM Zn2+ 
induced a greater degree of swelling in isolated mitochondria than 50uM Ca2+ (Jiang et al 
2001).  Xia et al (2009) have demonstrated an increase in intracellular Ca2+ flux, lowering 
mitochondrial membrane potential, and increased apoptosis in RAW 264.7 macrophages 
treated with 50 ug/ml ZNPs, suggesting Zn2+-induced ROS as the mechanism responsible 
for ZNP-toxicity.   
Although there are numerous studies correlating dissolved zinc to cytotoxicity, a 
causative link is lacking.  Furthermore, there have been no studies that have been able to 
elicit the same toxic effects as ZNPs with highly concentrated solutions of dissolved zinc 
salts (Applerot et al 2009).  Some studies have looked for a role in release of ROS from 
the ZNP surface, rather than the release of zinc.  Dissolution of Zn2+ from nano-ZnO is 
driven by imperfections in its crystalline structure, which are more prevalent in 
nanoparticles in comparison to bulk materials (Hanley et al 2009).  Higher structural 
disorder means more interstitial zinc ions able to dissolve and interact with cells, but as 
crystalline disorder and interstitial zinc increases, so does the number of oxygen 
vacancies (Applerot et al 2009).  In aqueous solution, these oxygen vacancies produce 
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highly reactive hydroxyl radicals (OH•) by splitting water molecules.  In an aqueous 
suspension of 10 ug/ml ZNP, electron spin resonance spectroscopy (ESR) measurements 
indicated that the bulk concentration of OH• was 15 uM (±25%, Applerot et al 2009).  
Another unique property inherent to nano-sized ZnO is the substantial presence of 
electron-hole pairs (e--h+) pairs available to serve in redox reactions (Yang et al 2008).  
Conduction band electrons react with dissolved oxygen molecules to generate superoxide 
radical anions (•O2-) and hydrogen peroxide (H2O2) through the peroxide anion radical 
(HO2•), as shown in Figure N.  These ROS can potentially cause cellular damage by 
triggering redox-cycling cascades within the cell.  Highly reactive ROS, such as OH•, 
have significant potential to permeate the cell membrane and damage biomolecules, 
resulting in such irreparable harm as DNA strand breaks (Applerot et al 2009).  
 
e- + O2 → •O2-;          •O2- + H+ → HO2•;          HO2• + H+ + e- → H2O2 
 
Figure 1:  Production of various ROS by ZNP conduction band electrons 
reacting with water. 
 
ZNP surface-produced ROS, like Zn2+ dissolution, would also be capable of 
inducing cells to produce endogenous ROS.  Exogenous H2O2 is widely known to trigger 
intracellular ROS in various cell types  (Grzelak et al 2001). It can be predicted, 
therefore, that ZNP surface-produced ROS elicit a similar response.  ROS are formed 
after a rapid sequence of events in phagocytic cells known as an oxidative burst, at which 
point metabolism is increased, the shape and size of the cell changes (Brunner et al 
2006), and phagocytosis occurs at a higher rate (Long et al 2006).  This process triggers 
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intracellular calcium release, which can then decrease mitochondrial membrane potential 
and trigger apoptosis.  Notably, this is the same pathway proposed to occur in response to 
exposure to dissolved Zn2+ (Xia et al 2008), but the authors neglected to rule out a 
possible role of surface-produced ROS.  Like the role of Zn2+ in MFF, oxidative stress 
can also initiate a proinflammatory response characterized by release of various 
cytokines.  Hanley et al (2009) demonstrated a correlation between ZNP exposure, ROS 
production, and increased expression of proinflammatory cytokines, IFN-γ, TNF-α, and 
IL-12.   
Given the plethora of literature documenting Zn2+ dissolution and ROS surface 
release from ZNPs, and the fact that both are influenced by the same crystallinity 
properties, both processes are most likely occurring in an aqueous ZNP suspension.  It is 
unclear, however, that one or the other is directly responsible for the observed 
nanotoxicity.  Additionally, the roles of endogenous ROS and extracellular signaling 
between cell types are still unclear, and they have yet to be situated within the framework 
of ZNP toxicity. 
 
1.3. PEGylation to prevent nanoparticle uptake 
 The conjugation of polyethylene-glycol (PEG) to nanoparticles is a drug delivery 
technique that enhances circulatory half-life by shielding the particle from plasma protein 
adsorption.  By blocking protein adsorption, the PEG layer makes the conjugated material 
less likely to be identified and ingested by circulating phagocytic cells, such as 
macrophages (Liufu et al 2004).  Thus, the particle remains in circulation for a longer 
period of time before it is cleared.  When examining nanoparticles’ interaction with 
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phagocytic cells of the immune system, PEGylation holds potential as a helpful tool to 
evaluate the impact of preventing particle internalization with regards to nanotoxicity.  
This thesis describes the design of a PEGylated ZNP and its effect on zinc oxide 
nanotoxicity in immune cell cultures. 
 To design a successful PEG coating, two main mechanisms of protein adsorption 
must be prevented: (a) protein diffusion through the PEG molecules and adsorption to the 
particle surface, and (b) protein adsorption onto the PEG itself due to protein interactions 
with molecular orientation of PEG (Pasche et al 2005).  To prevent adsorption via 
mechanism a, the PEG layer must be sufficiently dense to act as a steric barrier, 
physically blocking access of diffusing proteins to the particle surface.  Densities are 
typically maximized by grafting the chains close to one another on the particle surface.  
The minimum effective distance between engraftments has been estimated to be 
approximately 1.4 nm, or one PEG chain for every 2.1 nm2 (Gref et al 2000). By using 
high molecular weight PEG molecules (5,000-10,000 Da), the high-density barrier can be 
sustained over relatively thick brushes.  Regarding mechanism b, the degree of hydration 
of a PEG brush has been shown to correlate with its effectiveness in resisting protein 
adsorption.  This is because the hydrated PEG layer creates a hydrophilic barrier which 
resists the hydrophobic surface of proteins (Pasche et al 2003).  
 A method for PEGylation of ZnO nanoparticles is described by Liufu et al (2004) 
whereby PEG chains are bound through hydrogen interactions to the particle surface.  
The surface chemistry of ZnO is dependent on the pH of its solvent.  As pH decreases, 
the number of –ZnOH and –ZnOH2+ increases and the number of –ZnO- groups 
decreases, which optimizes the potential for hydrogen bonding between the ZNP surface 
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and PEG molecules.  In these conditions, PEG self adsorbs to ZNP in a dense coating.  
This principle was utilized in an attempt to synthesize a protein adsorption-resistant PEG 
coating to prevent cellular uptake by monocytes.  
 
2.  THESIS OBJECTIVES 
 The goal of this thesis is to clarify the mechanisms involved in zinc oxide 
nanotoxicity in immune cell cultures by designing a modification to zinc oxide 
nanoparticle suspensions.  To achieve this objective, a systematic study will yield insight 
toward which specific nanoparticle properties may elicit a toxic response.  Insight gained 
from nanoparticle modification will serve as a platform for future development in 
designing nanotechnologies that exploit the unique properties of nano-ZnO while 
preventing toxicity.  
 
2.1. Design Criteria 
• Significantly (p <0.05) reduce cytotoxicity. ‐ The design must reduce the toxic effect of the nanoparticles. 
• Account for interactions between various immune cell types. ‐ Because of the intimate and complex communication network of the immune 
system, experiments should utilize co-culture conditions to permit interactions 
between immune cell types (T cells, B cells, and monocytes).  
• Identify a specific mechanism of toxicity. ‐ Isolate or inhibit specific properties of the nanoparticles to elucidate a toxic 
mechanism. 
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2.2. Constraints 
• Use commercially available nanoparticles. ‐ This is necessary for consideration of properties left over from manufacturing 
processes.  Additionally, it prevents introduction of confounding variables that 
may arise from nanoparticle synthesis. 
• Static culture conditions. ‐ PEG function (decreasing particle uptake by limiting protein adsorption) is 
optimal in flow conditions.  Static culture techniques are well-established for 
immunological methodology and were therefore utilized in this study, at the 
expense of optimal PEG function.  
• Murine cells. ‐ Rather than using human peripheral blood mononuclear cells (PBMCs), cells 
were harvested from mouse spleens to permit future in-vivo studies. 
 
2.3. Study Design 
The study of ZnO nanotoxicity was categorized into a two main components.  
First, a preliminary assessment of toxic nanoparticle properties was performed to grasp 
the broad effects of each parameter on cell cultures.  Next, individual mechanisms were 
evaluated by designing inhibitory modifications to the nanoparticles.  A flow chart 
outlining the design process is drawn in Figure 2. 
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Process of Nanotoxicity Investigation 
 
Figure 2:  Flow chart outlining the general process of the study.  Solid boxes 
represent subjects of investigation and dashed boxes represent testing strategies. 
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3. MATERIALS AND METHODS 
 
3.1. Nanoparticle Preperation 
 For preliminary, comparitive nanotoxicity studies, 10nm diameter gold 
nanoparticles (GNPs) were synthesized following a common procedure.  500uL of 1% 
chloroauric acid was added to 30mL of filtered DI H2O, and 650uL 1% citric acid was 
added after boiling.  The solution was then dialyzed overnight to remove excess citric 
acid.  The average GNP diameter was quantified by UV-Vis spectra, indicating a mean 
particle size of ~12nm. 
 All titanium dioxide nanoparticles (TNPs) and ZNPs of various sizes were 
purchased from Sigma except for the <10nm ZNPs, which were purchased from Strem 
Chemicals (Newburyport, MA).  TNPs and ZNPs were dissolved in Hank’s Buffered Salt 
Solution (HBSS) using bath sonication for 20 minutes.  Nanoparticle dispersions were 
prepared the day of experimentation. 
 
3.2. Toxicity Assays Using Immunostaining and Flow Cytometry 
 Unless otherwise stated, all toxicity studies were performed on freshly isolated 
splenocytes harvested from wildtype mice purchased from Jackson Laboratories.  Spleens 
were passed through a 40um cell strainer, and urethrocytes were hydrolytically lysed 
using AKC solution (4.0g NH4Cl, 0.5g KHCO3, 100uL 0.5M EDTA pH 8.0, in 500mL 
dH2O).  Cultures of 1.0 x 106 cells/ml/well were incubated at physiological temperature 
(37°C) in 4% CO2 in 24-well plates.  A transferrin-enriched growth media was used 
throughout the studies to optimize basil viability of splenocytes.  The media is composed 
of RPMI 1640, enriched with 10% fetal bovine serum (FBS), 1% L-glut, 1% Penn/Strep, 
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1% HEPES, 1% sodium pyruvate, 1% MEM, 0.4% β-mercaptoethanol, and 0.05% 
transferrin. 
 After incubation, cells were transferred to 5.0 ml polystyrene FACS tubes.  
Monocytes were removed from wells by incubating with 250mM EDTA for 20 minutes 
at 37°C.  Cells were then stained for surface receptors so that their cell type could be 
identified using flow cytometry.  Cells were stained with antibodies on ice in the dark for 
30 minutes.  Cell types were identified by positive receptor expression as shown in Table 
1. 
 
 CD3 CD4 CD8 CD11b CD11c CD19 
CD4 T cells + + - - - - 
CD4 T cells + - + - - - 
Monocytes - - - + + - 
B cells - - - - - + 
 
Table 1:  Cell type definition by surface receptor expression. 
 
To quantify cell death, two stains were used, each acting through separate 
mechanisms to identify different types of death.  Annexin V was used to stain for the 
presence of phosphatidylserine (PS), a protein which is normally integrated within the 
inner layer of the bi-layered lipid membrane.  During the first stages of apoptosis, PS 
relocates to the outer membrane due to the inactivation of the enzyme flipase.  Annexin V 
binds to PS and is thus present on the membrane of apoptotic cells. 
For time course studies, Annexin V staining was performed in conjunction with a 
Live/dead staining (Invitrogen) to track the progression of apoptosis.  The Live/dead stain 
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binds nucleic acids within the cell, indicating loss of plasma membrane integrity.  This 
membrane disruption may be a result of either late-stage apoptosis or necrosis.  Cells that 
are Annexin V positive and Live/Dead negative are undergoing early apoptosis (PS has 
translocated but the membrane is intact).  Cells that are doubly positive both for Annexin 
V and Live/dead indicate that PS has translocated and the membrane is broken, therefore 
cells are in late-stage apoptosis or necrotic.  Table 2 summarizes the staining results for 
different degrees of cell death.  Cells were stained with Live/dead stain for 20 minutes at 
25°C in the dark prior to staining with antibodies. 
 
 Annexin V Live/Dead 
Live - - 
Apoptotic + - 
Late Apoptotic/Necrotic + + 
 
Table 2:  Viability characterization by staining positivity. 
 
 After staining, cells were fixed with 1% paraformaldehyde.  Samples were kept 
on ice in the dark until being run on either FACS Calibur or FACS Aria flow cytometer 
(BD Biosciences).  50,000-100,000 events were recorded to ensure a significant 
population number after several generations of gating.  Flow cytometry data was 
analyzed using FlowJo software (TreeStar, San Carlos, CA). 
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3.3. Polyethylene-glycol (PEG) Encapsulation of ZnO Nanoparticles (PEG-ZNP): 
3.3.1. Synthesis: 
 Zinc oxide nanoparticles with a diameter of up to 100nm (purchased from Sigma-
Aldrich) were encapsulated using a procedure modified from Liufu et al (2004).  100 mL 
volume of 15 mg/mL solution was prepared by suspending the nanoparticles by 
sonication for 15 minutes.  The solution was then brought to a pH of 8.5 with the addition 
of concentrated NaOH and sonicated again for 10 minutes.  A 5% weight/weight PEG 
concentration was selected due to its optimal inhibition of protein adsorption as 
previously reported (Gref et al 2000).  To ensure an even distribution of PEG adsorption, 
0.75 g PEG (MW=6,000) was first dissolved in 100 mL diH2O, and 10 mL of this 
solution was added to the nanoparticle solution.  After stirring for 24 hours to allow PEG 
adsorption to take place, the encapsulated nanoparticles were washed with diH2O, 
reconstituted in diH2O, and lyophilized overnight.   
 
3.3.2. Characterization: 
3.3.2.1. Particle size measurement. 
Size of PEG-ZNPs, Catalase-PEG-ZNPs, and naked ZNPs was determined by 
dynamic light scattering (DLS) using a Zetasizer Nano (Malvern Instruments, 
Worchestershire, UK).  Nanoparticles were dispersed in diH2O at 5 mg/mL and sonicated 
for 5 minutes immediately prior to measurement.  Refractive indices for ZnO and H2O 
were set at n=1.9 and n=1.33, respectively.  PEG coating thickness was calculated by 
subtracting the radius of PEGylated nanoparticles by that of non-PEGylated 
nanoparticles. 
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3.3.2.3. Microscopy for visualization of cellular uptake 
 In conjunction with the protein adsorption assay for the assessment of cellular uptake 
potential, we hoped to visualize preferential ZNP uptake into cells by fluorescent 
microscopy.  ZnO autofluoresces at an excitation and emission wavelengths of 320nm 
and 385nm, respectively, and nano-sized ZnO particles have been shown to exhibit an 
enhanced photoluminescence in comparison to their bulk counterparts (Zvyagin et al 
2008).  Using a Tecan spectrometer, we measured the absorption/emission spectra for 
ZNPs in HBSS buffer at a concentration of 2mg/mL.  Based on this data, shown in Figure 
Z, the appropriate filter was unavailable for visualization on the fluorescent microscope 
(Leica).   
 As an alternative, dark field microscopy was employed to visualize the particles.  
ZNP and PEG-ZNP samples were prepared at 250 ug/mL in PBS and HBSS and 
observed using 10x and 40x objectives in dark-field conditions.  To visualize their uptake 
into murine monocytes, splenocytes were seeded onto 2 and 4-well chamber slides at 
2x106 and 6x106 cells, respectively.  Non-adherent cells were removed by replacing the 
media after 4 hours, and nanoparticles at 50ug/mL were introduced.  Adherent cells were 
incubated with PEG-ZNPs and naked ZNPs for 2 hours and 4 hours, and one sample of 
cells was left without nanoparticles to serve as a control.  After nanoparticle incubation, 
the media was removed and cells were fixed with 4% paraformaldehyde (PFA) and 
washed with 5mM glycine in PBS to removed excess PFA.  Samples were subsequently 
washed 2x with pure PBS and treated with Vectashield for preservation.  Samples were 
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then observed with 10x and 40x objectives using bright-field microscopy to visualize the 
cells and dark-field microscopy to illuminate the nanoparticles. 
 
3.3.2.2. Protein absorption assay 
 To characterize the effect of PEGylation on ZNPs, the quantity of protein adsorbed 
to the nanoparticle surface was measured using spectroscopy.  To best mimic the 
experimental conditions, sample preparation was identical to that of the toxicity assays 
excluding cells.  PEGylated and naked ZNPs were dispersed in HBSS at 250 ug/ml, and 
200 ug of each dispersion was added to 800 ul RPMI media enriched with 10% fetal 
bovine serum (FBS).  The final particle concentration was 50 ug/mL, and each sample 
was incubated in a 24-well plate for 2 hours.  After incubation, each sample was 
transferred to a polypropylene tube and centrifuged at 2500 rpm for 10 minutes to collect 
the nanoparticles in a pellet.  The pellets were each reconstituted in 200 mL HBSS and 
absorbance at λ=280nm was read on a NanoDrop UV-Vis spectrophotometer (Thermo 
Scientific). 
 
3.4. Sequestering Zinc Cation Dissolution 
 To identify whether extracellular dissolved zinc cations (Zn2+) play a role in 
cytotoxicity, the cell-impermeant zinc chelator, calcium-saturated EDTA (CaEDTA) was 
added to the cultured cells.  Previous studies show that dissolved Zn2+ stabilized at 
100uM in cell culture medium (Xia et al 2008), so a concentration of 100uM CaEDTA 
was selected due to the 1:1 molar ratio of Zn2+ chelation by CaEDTA.  High 
concentrations of EDTA was avoided due to its toxic potential to lymphocytes.  EDTA 
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was purchased from Sigma and saturated with an equimolar concentration of CaCl2 to a 
final concentration of 250mM.  Prior to addition to cultures, CaEDTA was premixed with 
a freshly-prepared, 250 ug/ml stock solution of ZNPs to chelate dissolved zinc cations 
before their contact with cells. 
 
3.5. Inhibition of ZNP-Surface Produced ROS 
Investigation of extracellular ROS produced at the nanoparticle-solution interface 
was carried out using two antioxidant methods.  To quench any H2O2 produced 
extracellularly, cells were incubated with catalase (Sigma), a membrane-impermeable 
enzyme that is endogenous to cells and catalyzes the decomposition of H2O2 into H2O.  
Catalase was freshly prepared in 50 mM potassium phosphate buffer at 1.0 mg/ml (as per 
manufacturer protocol) and added to cells at either 200 units (U) or 2,000 U per sample. 
Catalase was preincubated with splenocyte cultures for 15 minutes prior to addition of 
ZNPs to ensure optimal enzymatic activity.  Treatment with 5,5-Dimethyl-1-pyrroline N-
oxide (DMPO), a membrane-permeable nitrone spin trap, was employed to trap free 
hydroxyl radicals (OH•) produced at the ZNP surface.  DMPO will also quench 
superoxide radicals (•O2-), although •O2- are not as reactive in a physiological 
environment and are less likely to cause cellular damage (Applerot et al 2009). DMPO 
does not quench H2O2 (Britigan et al 1991).  100uM DMPO was added to the culture 
simultaneously with ZNPs.  Table 3 outlines the three ROS that may be quenched using 
DMPO or catalase.  After the addition of nanoparticles, cells were cultured for 8 hours. 
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ROS Name Formula Quenching Agent 
Physiological 
Reactivity 
Hydroxyl Radical HO• DMPO Very High 
Hydrogen Peroxide H2O2 Catalase High 
Superoxide Anion  •O2- DMPO Low 
 
Table 3:  ZnO nanoparticle-produced ROS that may exist extracellularly. 
 
3.6. Detection of Intracellular ROS 
 To detect and quantify the ROS level within cells, fluorinated 2’,7’-di-
chlorofluorescein diacetate (H2DFFDA) was purchased from Molecular Probes (Eugene, 
OR) and used for cell staining.  H2DFFDA is a cell-permeable dye, which fluoresces 
upon removal of its acetate group by intracellular esterases and subsequent oxidation.  
The excitation/emission of its oxidized form is 500/530 nm, and thus detectable by the 
FITC channel on the flow cytometer. 
 Using flow cytometry to quantify the level of oxidized H2DFFDA, we could 
specify which individual cell type produce ROS in response to ZNP exposure.  Therefore 
a protocol was developed and optimized whereby cell cultures were stained with 
H2DFFDA, followed by cell-specific antibody staining.  As a positive control, hydrogen 
peroxide (H2O2) was used at a concentration of 100µM to induce ROS.  In ROS-positive 
controls, cells were treated with H2O2 for 30 minutes before loading H2DFFDA.  To 
avoid extracellular activation of H2DFFDA by loss of its acetate group before it 
permeates the cell, H2DFFDA was loaded in serum-free Hank’s Buffered Salt Solution 
(HBSS).  Thus, following culture in growth media, cells were washed once with HBSS 
before loaded with H2DFFDA.  Cells were then loaded with 10µM H2DFFDA in HBSS 
for 30 minutes at physiological temperature (37°C).  Following loading, cells were 
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allowed a 15-minute recovery time in transferrin-enriched growth media at 37°C.  The 
cells were then washed with 4°C FACS buffer, stained with antibodies on ice as 
previously described, and fixed in 1% paraformaldehyde.  Notably, fixing has no effect 
on H2DFFDA because the dye is not bound to cellular components, but was done to 
ensure that the procedure could be applied to future human studies, which must be fixed 
as a safety precaution.  After antibody staining, cells were immediately run on either a 
FACS Caliber or FACS Aria flow cytometer. 
 After determining the optimal conditions that would comprise the standard 
intracellular ROS quantification procedure, ZNP-induced ROS was quantified as per the 
developed protocol.  Antibodies were used to detect the presence of CD3, CD4, and CD8 
(T cell markers); CD19 (B cell marker); and CD11b and CD11c (monocyte markers).  
Annexin V was also included to quantify cell death.  
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4. RESULTS AND DISCUSSION 
4.1. Nanotoxicity Studies 
4.1.1. Nanotoxicity is Dependent on Chemical Composition of Nanoparticles 
Cell death was assessed by staining with Annexin V and subsequently measured 
by flow cytometry.  As a cell passes through the flow cytometer, the fluorescence 
intensity at that wavelength indicates whether the cell is positive or negative for Annexin 
V, and thus whether the cell can be characterized as viable or dead.  Fifty thousand to 
one-hundred thousand events were collected for each sample to ensure that an adequate 
number of cells were characterized to achieve statistical significance. 
Figure 3 shows a significant increase in cell death after exposure to ZnO 
nanoparticles in comparison to control cells. Only 20% of lymphocytes survive when 
exposed to ZnO NPs for 42 hours compared to the unexposed control cells. Neither TiO2 
nor gold nanoparticles effected cell viability. 
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Effect of Nanoparticle Composition on Toxicity 
 
  
 
Figure 3:  Effect of nanoparticle composition on toxicity of freshly isolated 
murine splenocytes at 50 ug/mL.  Cells were incubated with nanoparticles for 42 
hours. Cytotoxicity was determined by Annexin V staining using flow cytometry. 
(p=0.05, n=2). 
 
  
Because ZnO was the only tested nanomaterial to show a positive cytotoxic 
response, the decision was made to solely study ZnO nanoparticles to study which 
properties impart their unique nanotoxicity. 
 
4.1.2. Effect of nanoparticle concentration and nanoparticle size on immune cell toxicity 
Cells were isolated as described above.  Nanoparticle suspensions of various 
particle sizes were prepared and incubated with cells and toxicity measured by flow 
cytometry.  Figure 4 demonstrates that cell viability decreases significantly at a ZnO 
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nanoparticle concentration of 50 ug/mL in all cell types, and CD8 T-cell viability 
decreased after exposure to 10 ug/mL of ZnO nanoparticle solution. 
 
Dose Response of ZnO Nanoparticles 
 
 
 
Figure 4.  Dose response of murine splenocytes after exposure to <100nm ZnO 
nanoparticles for 42 hours.  Viability was determined by Annexin V staining 
using flow cytometry and cell counting. (p=0.05, n=4). 
 
Figure 5 depicts the effect of ZnO nanoparticle size on cell toxicity.  T-cell data 
indicates that 10nm ZnO nanoparticles are minimally less toxic than larger sized 
nanoparticles.  This data opposes the common belief that nanoparticle toxicity increases 
as size decreases.  Importantly, the 10 nm particles were purchased from a different 
vendor than the 50 and 100 nm particles, suggesting a possible role of manufacturing 
process in the toxic potency on the nano-scale.  Nanoparticle size measurements, 
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described later, characterized the 100 nm ZNPs as actually quite smaller than advertised, 
which probably explains the lack of toxicity difference between “50” and “100 nm” sizes. 
 
Effect of ZnO Nanoparticle Size on Toxicity 
 
 
 
Figure 5.  Effect of ZnO nanoparticle size on cytotoxicity of 
murine splenocytes after 42 hours, at 50 ug/mL.  Viability was 
determined by Annexin V staining using flow cytometry and 
normalized to untreated controls.  (n=2). 
 
 
4.1.3. Time Course Studies 
The dynamics of interactions of nanoparticles with cells are important because 
they can provide insight on the mechanism of action help guide selection of surface 
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modification approaches to eliminate adverse effects. An AnnexinV staining was 
performed in conjunction with a Live/Dead staining to track the progression of apoptosis.  
Cells that are AnnexinV positive and Live/Dead negative are undergoing early apoptosis 
(PS has translocated but the membrane is intact).  Cells that are doubly positive both for 
Annexin V and Live/Dead indicate that PS has translocated and the membrane is broken, 
therefore cells are in late-stage apoptosis or necrotic. 
Figure 6 demonstrates how the length of exposure to ZnO nanoparticle affects cell 
toxicity.  Generally, cell viability begins to dramatically decline after twelve hours of 
exposure.  B-cells seem to be most vulnerable to ZnO nanoparticle-induced apoptosis, 
evidenced by a viability of less than 20% compared to the untreated controls after 18 
hours. 
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Time Course Study: ZnO Nanoparticle Toxicity 
 
 
 
 
Figure 6.  Time course study of murine splenocyte exposure to 100nm ZnO 
nanoparticles, at 50 ug/mL.  Cytotoxicity was determined by Annexin V staining 
using flow cytometry, and by Live/Dead stain and normalized to untreated 
controls.  (p=0.05, n=6). 
 
A series of time course experiments suggests that exposure to ZnO nanoparticles 
results in a gradual transition from early apoptosis to late-stage apoptosis over the course 
of 18 hours.  The marked decrease in cell viability between 12 and 18 hours may be due 
to the time required for the nanoparticles’ cellular uptake and subsequent pathway 
activation.  More detailed experiments coupled with microscopic imaging may enable 
further investigation into which specific pathways occur.  Figure 7 is a representative 
sample of flow cytometric data, taken from a 12-hour time point, which indicates the 
transition from early to late-stage apoptosis in CD4 T-cells. 
 
    29 
Representative Flow Cytometry Data 
 
 
 
 
Figure 7:  Representative Flow cytometry data (FACS Aria) from an exposure to 
100nm ZnO nanoparticle time course study.  Untreated CD4+ T cells after 8 
hours (A) 3.74% dead cells as measured by Annexin V and Live/Dead stain 
double positivity compared to 9.75% in cells treated with 50ug/mL ZnO 
nanoparticles for the same period of time (B).  At 12 hours, 6.7% of controls cells 
were dead (C), whereas 42.5% of cells treated with ZnO NP (D) were found to be 
dead.  Such double positive dead cell can be either late apoptotic cells or 
necrotic.  Our studies suggest that this death may be resulting from increased 
apoptosis as early apoptosis was also increased by ZnO treatment.  Cells that 
were AnnexinV positive and Live/Dead negative (plasma membrane is still 
intact, early apoptosis) increased from 1.84% in the control to 7.18% in treated 
cells. 
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4.2. Mechanistic Study of ZnO Nanotoxicity: Elucidating the Role of Reactive 
Oxygen 
 After several parameters governing ZnO nanotoxicity were evaluated, the 
mechanism through which the particles were killing cells was investigated.  Several 
studies suggest an increased level of reactive oxygen species (ROS) within cell cultures 
as a result of ZnO nanoparticle exposure (REF).  However, there is stark disagreement 
over the process by which ZNPs induce ROS (as outlined in “Background”).  The lack of 
understanding arises in large part from the uncertainty of whether the particles trigger a 
response from within the cell, after being internalized, or if ROS are initiated through a 
soluble factor released extracellularly by the ZNPs.  To show whether or not a causative 
link exists between cellular internalization and ROS/toxicity, a means to prevent ZNP 
internalization was designed by synthesizing a particle coating of polyethylene glycol 
(PEG).  If PEG prevents ZNP uptake and inhibits toxicity, it can be concluded that ZNP-
internalization is required to induce apoptosis.  Therefore, a PEG coating was designed, 
characterized, and tested on splenocyte cultures. 
 
 
4.2.1. Characterization of PEGylated ZNPs 
 The size of purchased ZNPs was determined to agree with the manufacturer’s 
claim of <100 nm diameter, although the average size of 23.92 nm was significantly 
smaller than the upper limit.  This may explain why there was no significant increase in 
toxicity between “100 nm” and “50 nm” diameter nanoparticles in the size-dependency 
experiments described previously.  Figure 8 shows the dynamic light scattering (DLS) 
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measurements of the size distribution of un-PEGylated ZNPs (dark lines) and PEG-ZNPs 
(light lines).  The clear shift of the PEG-ZNP curve to the right confirms that the 
PEGylation process successfully coated all nanoparticles, adding several nanometers of 
polymer to the surface. Table 4 lists the Z-average diameters of the nanoparticles and the 
thickness of the adsorbed PEG layer. The second peak in the intensity readout in Figure 8 
(intensity) likely represents agglomerated particles having an average diameter of 663.6 
nm.  That population disappeared after PEGylation because the adsorbed PEG coating 
helps to stabilize the particles in solution, preventing agglomeration.   
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Figure 8:  Nanoparticle size distributions as measured by dynamic light 
scattering (DLS).  ZNPs and PEG-ZNPs, represented by dark lines and light 
lines, respectively, were measured by intensity and volume. 
 
 
 Z-Average Diameter (nm) Adsorbed PEG Thickness (nm) 
ZNP 23.92 - 
PEG-ZNP 30.12 3.10 
 
Table 4:  Average nanoparticle size results from DLS. 
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The resulting PEG thickness measured 3.10 nm, which matched the expected 
diameter.  Liufu et al (2004) report that 6,000 Da PEG adsorption plateaus at 3.97 nm 
thickness on ZNPs, as measured by viscosity relations using rheometry.  Accounting for 
variability inherent to a comparison of different measurement techniques, it was thus 
concluded that PEGylation yielded optimal results and the modified particles were ready 
for use in in-vitro toxicity testing. 
 
4.2.2. PEGylating ZNPs Did Not Reduce Nanotoxicity in Splenocytes 
 After synthesis and characterization of PEG-ZNPs, the effect of PEGylation on 
ZNP toxicity was assessed by flow cytometry.  As shown by the data in Figure 9, PEG-
ZNP triggered the same degree of cytotoxicity as naked ZNP.  Untreated, 50ug/mL naked 
ZNP, and 50ug/mL PEG-ZNP treatments resulted in average cell viability percentages of 
44.45 ± 2.47, 11.03 ± 2.76, and 8.9 ± 3.14, respectively (n = 3, Figure 9a).  Figures 9b-d 
are representative flow cytometry data showing the percentage of apoptotic cells for one 
sample per treatment group.  Gates enclose the Annexin V-positive population, and the 
value within the gate defines the percentage of Annexin V-positive (apoptotic) cells. 
 Assuming that PEGylation reduces the particle’s uptake into cells, the fact that it 
does not inhibit ZNP toxicity suggests that the toxic mechanism acts through an 
extracellular pathway.  Two such mechanisms that have been proposed include; 1) 
production of ROS at the interface between the ZNP surface and its aqueous 
environment, and 2) dissolution of zinc cations (Zn2+) from the particle’s surface that 
subsequently penetrate the cell and trigger an oxidative burst.  Conversely, these data 
indicated that intracellular interactions are not responsible for ZNP-induced toxicity.   
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Figure 9:  Effect of ZNP PEGylation on mouse splenocyte toxicity after 20 hrs in 
culture at 50ug/mL NP concentration. a  PEGylation does not prevent ZNP-
induced viability decrease.  Asterisks denote statistically significant differences 
(p < 0.05).  b-d  Flow cytometry data showing the effect of PEGylation on ZNP 
toxicity.  The value inside the each gate represents the percentage of apoptotic 
cells as defined by Annexin V positivity.  Forward scatter is plotted on the y-axis.  
b Untreated control. c 50ug/ml ZNP-treated cells. d 50ug/ml PEG-ZNP-treated 
cells.  (p=0.05, n=3). 
 
 
4.2.3. PEGylation Failed to Prevent ZNP Internalization into Monocytes  
 To rule out the possibility that PEG-ZNP toxicity was due to the failure of 
PEGylation to prevent cellular uptake, differential internalization within the two 
nanoparticle samples was qualitatively evaluated by microscopic imaging.  ZnO exhibits 
(a) 
    35 
a weak autofluorescent emission at 385 nm when excited with 320 nm light (Zvyagin et 
al 2008).  To confirm this spectra, the fluorescence was measured as described above, 
and the results (Figure 10) match the published excitation/emission spectra, showing a 
peak in fluorescence at 385 nm. 
 Such a short wavelength would have required the purchase of a new filter for the 
available fluorescent microscope.  However, because the autofluorescence was possibly 
too weak to be visualized on the microscope should the 385nm filter become available, 
an alternative method was pursued for the study. 
 
 
 
Figure 10:  Fluorescence Emission Spectra of ZNPs of various concentrations at 
320 nm excitation, normalized with solvent controls.  At each concentration, 
emission intensity peaked around 385 nm. 
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 Dark field microscopy was selected as a more appropriate method to investigate 
ZNP internalization because ZNPs have been successfully imaged using dark field in the 
past.  Additionally, cells reflect a minimal amount of light in the dark field.  Therefore, 
by switching between bright field (where cells are visible and nanoparticles are not) and 
dark field (where cells are slightly visible and ZNPs shine brightly), the location of the 
particles relative to cells could be visualized. 
 Figure 11 shows bright field (a, c, e) and dark field (b, d, f) images of monocytes 
(indicated by white arrowheads) and remaining lymphocytes (as identified by the double 
arrowhead in 11a).  Figures 11a and 11b show a representative set of images of an 
untreated monocyte.  Notably, dark field imaging yielded only a faint glow in the position 
of the untreated cells.  In contrast, after 2 hours of 50 ug/ml ZNP treatment (11c-d) 
monocytes shined brightly under dark field conditions.  Lymphocytes remained invisible 
in the dark field, indicating no internalized particles.  Figure 11d shows the monocytes’ 
granular appearance imparted by ZNP endocytosis.  Unexpectedly, cells incubated with 
PEG-ZNPs for 2 hours (11e-f) appeared similar to the ZNP-treated cells in the dark field, 
indicating that PEGylation had little, if any, effect on nanoparticle uptake. 
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Figure 11:  Microscope images of PEGylation’s effect on nanoparticle 
internalization in monocytes after 2 treatment.  Corresponding bright field (a, c, 
e) and dark field (b, d, f) images clearly show cells in bright field while 
visualizing nanoparticles by their reflective properties under dark field 
(a) (b) 
(c) (d) 
(e) (f) 
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conditions.  a-b Untreated cells.  c-d Naked ZNP-treated cells.  e-f  PEG-ZNP-
treated cells. 
 
 The ineffectiveness of PEGylation may be due to several factors.  First, treatments 
were performed in 24-well plates which remained motionless in the incubator.  PEG’s 
effectiveness in preventing phagocytic clearance is optimal in flow conditions, such as 
that of the bloodstream, because its degree of serum protein repulsion is enhanced when 
proteins are in motion relative to the PEGylated particle.  In a static culture environment, 
small proteins may be more likely to encounter unprotected portions of the ZNP surface 
and stick.  Also, ZNPs and PEG-ZNPs sink to the bottom of the well and inevitably come 
in contact with the cells.  In the absence of flow, phagocytic cells such as monocytes have 
ample opportunity to injest the foreign material.  
 Another possible reason for PEG-ZNP’s unhindered internalization may involve 
the nature of the PEG-ZNP association itself.  A typical PEG attachment is accomplished 
through the activation of one of its termini and subsequent covalent bonding to the 
material.  This technique is commonly used to graft PEG chains onto a polymeric particle 
to create a brush, which can surround and protect the particle from adsorbed proteins.  
However, because the surface chemistry of ZnO is not conducive to covalent bonding 
with PEG, a different conjugation method was employed whereby the polymer was 
physically adsorbed to the nanoparticle surface.  This method yields a significantly 
thinner coating of PEG (DLS measurements indicated a PEG coating of 3.1 nm, Figure 
U), since hydrogen bonding may occur once or more along the polymer chain rather than 
one end being covalently tethered to the particle surface.  A schematic depicting the 
difference in PEG architecture between these two methods is illustrated in Figure 12: 
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Figure 12:  Schematic illustrating the difference in PEG architecture between a 
H-bonded physical adsorption method and b covalent grafting. 
 
Protein adsorption may be permitted by the thinness of the PEG layer produced 
by H-bonded conjugation, or it may be that the adsorbed PEG has a lower degree of 
hydration in comparison to that of the grafted brush surface architecture.  The H-bonded 
PEG may not have permitted the unique water structure that gives grafted PEG brushes 
their hydrophobic shield.  Therefore, even if PEG surface density was high enough to 
prevent protein adsorption to the ZNP surface, proteins may have bound to the PEG layer 
itself.  To evaluate whether PEG-ZNP conjugation methodology was invalid or the static 
culture conditions permitted uptake of well-PEGylated nanoparticles, protein adsorption 
assays were performed. 
 
4.2.4. H-bonded PEG was Insufficient to Significantly Resist Protein Adsorption 
 Protein adsorption to ZNPs and PEG-ZNPs was quantified by measuring the 
absorption at 280 nm (A280).  ZNPs were found to adsorb 10.13 ± 1.98% of their weight 
in protein, while PEG-ZNPs adsorbed 8.38 ± 0.85%, as shown in Figure 13.  Although a 
slight difference in adsorption was recorded, the samples were not statistically significant 
(n=4).   
(a) (b) 
ZNP 
PEG 
H-bonded 
adsorption 
Covalent 
Grafting 
    40 
 
Figure 13:  Differential protein adsorption between non-PEGylated and 
PEGylated ZNPs, in weight of protein by weight of ZNPs as measured by A280. 
(p=0.05, n=4). 
 
 The inability for the PEGylation to resist protein adsorption implies that H-
bonding PEG chains to ZNPs is not an effective technique to prevent nanoparticle uptake, 
whether cells are cultured in static or flow conditions.  In a flow environment, such as 
blood circulation, nanoparticles are more likely to frequently encounter proteins.  
Without a covalently grafted PEG brush to maximize hydrophilicity and steric hindrance, 
ZNPs will adsorb dissolved proteins regardless of static or dynamic conditions. 
 
4.2.5. Chelating Dissociated Zn2+ Did Not Mitigate Nanotoxicity 
 Because PEGylation did not effectively limit cellular internalization, an 
alternative approach to assessing the role of extracellular Zn2+ was employed.  100 uM 
EDTA, a membrane-impermeable zinc chelator, was added to splenocyte cultures treated 
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with 50 ug/ml ZNP to prevent Zn2+ from entering cells and causing any cytotoxic effects.  
Zinc chelation by EDTA had no effect on nanotoxicity as measured by AnnexinV 
positivity.  In cultures treated with both ZNPs and EDTA, about half of all cells stained 
positive for apoptosis, the same frequency as ZNP-treated cultures alone.  AnnexinV 
positive populations among all splenocytes are gated against forward scatter (FSC) in the 
graphs of Figure 14 below. 
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Effect of Extracellular Zn2+ Chelation on ZnO Nanotoxicity 
 
 
Figure 14:  Extracellular Zn2+ chelation with 100uM EDTA treatment was 
ineffective in mitigating ZNP-induced toxicity after 8-hour incubation.                  
a  Untreated splenocytes.  b  EDTA treatment without ZNPs.  c  ZNPs alone.       
d  EDTA with ZNPs.  (n=1). 
  
These results indicate that dissolution of zinc cations from the nanoparticle 
surface in the extracellular environment has no significant role in the toxic pathway.  It 
cannot be ruled out, however, that this process does not contribute to cell death once 
internalized, since the cell membrane is impermeable to EDTA.  To determine whether 
zinc exists inside the cell, cells can be stained with Newport Green or 6-methoxy-(8-p-
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toluenesulfonamido)quinoline (TSQ), which bind to zinc cations.  However, it would be 
difficult show a cause-and-effect relationship between intracellular zinc and apoptosis, 
especially since the toxicity pathway ascribed to Zn2+ is similar to that of any ZNP-
induce oxidative stress, including surface-released ROS.  For this reason, the next 
experiments investigate the toxic potential of extracellular ROS, since zinc cation 
chelation would not effect extracellular ROS. 
 
4.2.6. Inhibiting Extracellular ROS  
 Catalase, a membrane-impermeable antioxidant enzyme, was employed as a H2O2 
quencher so that any effect could be attributed to an extracellular pathway.  We tested to 
see whether free catalase added to the growth media had an inhibitory effect on ZNP-
induced toxicity in mouse splenocytes.  Exogenous catalase was found to reduce total 
apoptosis as quantified by the AnnexinV toxicity assay using flow cytometry as 
previously described.  Each graph in Figure 15 shows flow cytometry data for 50 ug/ml 
ZNP-cultured splenocytes after an 8 hour incubation, with AnnexinV positivity on the x 
axis and forward scatter (FSC) on the y axis.  The effect of OH• trapping with DMPO 
(15-c) was insignificant compared to ZNP-only control (15-b).  Extracellular H2O2 
consumption by 200U catalase (15-d) resulted in inhibition of apoptosis by 65% in when 
compared to untreated control (15-a).  Incubation with 2000U catalase (15-e) reduced 
apoptosis by 83%. Figure 16 shows catalase inhibition in terms of the shifting mean 
fluorescence intensity (MFI) of AnnexinV within the apoptotic population.  The 
decreasing MFIs of uninhibited ZNP, 200 U catalase, and 2,000 U catalase  (66.8, 37.5, 
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and 29.4, respectively) represent a suppressed expression of PS, possibly as a result of 
delayed onset of apoptosis. 
 
Effect of Extracellular ROS Inhibition 
 
 
Figure 15:  Reduction of apoptosis within the entire splenocyte population by 
quenching extracellular ROS.  The degree of AnnexinV positivity is plotted on 
the x-axis, while forward scatter (FSC) is shown on the y-axis.  c  The effect of 
OH• trapping with DMPO was insignificant compared to  b  ZNP-only control.  d  
Extracellular H2O2 consumption by 200U catalase resulted in inhibition of 
apoptosis by 65% in when compared to  a  untreated control.  e  Incubation with 
2000U catalase reduced apoptosis by 83%.  Results are representative of two 
separate experiments. 
 
 
a b c 
d e 
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Decreased PS Expression After Catalase Treatment 
 
Figure 16:  Illustration of reduced expression of PS within apoptotic cells with 
catalase treatment.  Geometric means calculated from the gated AnnexinV+ 
population. 
  
The effectiveness of exogenous catalase in reducing ZNP-induced toxicity 
indicates that ZNP treatment introduces H2O2 into the extracellular environment, which is 
at least partially responsible for splenocyte apoptosis.  Whether H2O2 is directly produced 
as a result of a chemical reaction at the particle surface is unclear.  For this to be the case, 
a conduction band electron would react with dissolved O2 to form •O2-, which would then 
bind two protons to produce one molecule of H2O2.  (See Figure 1.)  Given the results of 
the DMPO treatment, this scenario seems unlikely.  In addition to OH•, DMPO traps •O2-, 
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which is required for the cell-independent formation of H2O2.  Since DMPO treatment 
failed to significantly inhibit apoptosis, H2O2 release from the ZNP surface is not likely 
the mechanism of toxicity.  Toxic extracellular H2O2 must have a different origin. 
 The extreme reactivity of OH• makes it difficult to quench high concentrations in 
in-vitro conditions, because their chance of encountering biological materials before 
contacting electron spin traps like DMPO is considerable.  This is especially true when 
particles are in contact with the lipid membrane or internalized in endosomes, which has 
been shown to be true in the dark-field microscopy studies.  It is possible that DMPO was 
ineffective for this reason and that OH• damage may play a role in cytotoxicity.  If OH• 
damages cells through dissociation from internalized or membrane-associated ZNPs, the 
reduction of apoptosis through catalyzing extracellular H2O2 would suggest toxicity is 
transmitted through cellularly produced H2O2 released from monocytes as a result of 
toxic oxidative stress. 
 Assuming that DMPO was affective in quenching any ZNP surface-produced 
OH•, the effectiveness of catalase to reduce nanotoxicity indicates that H2O2 has one of 
two distinct origins.  As previously mentioned, monocytes are able to release H2O2 as a 
response to toxic oxidative stress (Melo et al 2003).  It is possible that catalase rescues 
splenocytes from apoptosis by quenching a toxic concentration of cellularly-released 
H2O2.  The other possible origin of toxic H2O2 is from the reaction at the ZNP-aqueous 
interface, prior to coming in contact with the cell.  A schematic illustrating the two 
pathways is shown in Figure 17: 
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Figure 17:  Schematic depicting the two potential points of catalase inhibition of 
ZNP-induced nanotoxicity.  a  ZNP surface produced hydrogen peroxide (H2O2) 
is quenched before it breaches the cell membrane.  b  The cell releases H2O2 in 
response to ZNP-induced oxidative stress, and catalase quenches it prior to its 
toxic effect on neighboring cells. 
 
 By showing that catalase inhibits nanotoxicity, it is clear that extracellular H2O2 is 
directly involved in the toxic pathway of ZnO nanoparticles in splenocyte cultures.  To 
determine whether the criticial inhibition of catalase occurs at location a; prior to 
interacting with the cell, or b; after an oxidative burst within the cell, intracellular ROS 
levels were assayed. 
 
4.2.7. Optimization of Intracellular ROS Detection Protocol 
To ensure optimal results from the intracellular ROS assay, and because the 
quality of DFFDA staining relies heavily on cell type and culture conditions, an 
intracellular ROS protocol was developed an optimized from mouse splenocytes.  A dye 
concentration of 10 uM was found to be superior to 1 and 5 uM.  A thirty-minute load 
time was more effective than 5 and 15 minutes, and no different than 60 minutes.  
Loading at physiological (37°C) temperature was more effective than at room 
temperature (25°C). H2O2 stimulation times of 15, 30, 60, and 90 minutes were tested, 
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and optimal ROS-induction was found to occur at 60 and 90 minutes.  The optimal H2O2 
concentration was identified as 100 uM in comparison to 200 uM, which induced slightly 
higher toxicity without an appreciable increase in DFFDA intensity.  Figure 18, 
comparing ROS-induction by 100 uM H2O2 with 200 uM, is a representative analysis of 
optimization experiments.  
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Stimulation of Intracellular ROS Production 
 
 
 
 
Figure 18:  Flow cytometry data demonstrating that 100 uM H2O2 stimulation is 
sufficient to induce ROS in mouse splenocytes.  Cultured cells were stimulated 
with H2O2 for 15 minutes, loaded with 10uM DFFDA for 30 minutes in serum-
free HBSS, followed by a 15-minute recovery time in growth media.  a-c  Gating 
on the cell population of total detected events for various H2O2 concentrations.  
d-f  Gating on lymphocyte populations (CD11b-negative cells, left gate) and 
monocyte populations (CD11b-positive cells, right gate) for various H2O2 
a b c 
d e f 
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concentrations.  g-h  Monocyte (g) and lymphocyte (h) expression of intracellular 
ROS after stimulation with 0uM, 100uM, and 200uM H2O2. 
 
4.2.8. Quantification of Intracellular ROS 
 After optimizing the intracellular ROS assay for murine splenocyte cultures, the 
role of intracellular ROS was investigated.  Previous studies have shown an increased 
intracellular ROS level in immune cell types (Hanley et al 2009), which agrees with our 
findings implicating a role of H2O2.  It has not been clarified, however, whether the 
documented ROS produced in immune cells triggers release of toxic H2O2 throughout the 
culture, or if H2O2 produced by the nanoparticles themselves triggers ROS production 
within cells.   
 Figure 19 shows the effect of ZNPs and catalase-inhibition on intracellular ROS, 
as measured by DFFDA positivity.  3.1% of untreated splenocytes were positive for 
intracellular ROS after 8 hour incubation with ZnO nanoparticles.  The addition of 50 
ug/ml ZNPs increased the number of DFFDA positive cells to 5.1%, and inclusion of 
200U catalase yielded the same percentage.  When incubated with 2,000U catalase in 
addition to ZNP, 10.1% of cells were positive for elevated ROS levels.   Table 5 shows 
the relative shift of the entire cell population toward a greater DFFDA intensity.  The 
average mean fluorescence intensity significantly (p=0.05) increases between untreated 
controls and ZNP treatment.  
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Figure 19:  Percentage of splenocytes positive for intracellular ROS as 
quantified by DFFDA positivity, after 8 hours of ZnO nanoparticle treatment.  
ZNPs significantly increase intracellular ROS relative to untreated control.  
Addition of 200U Catalase had no effect, and 2,000U Catalase approximately 
doubled the number of DFFDA positive cells. (n=2, p=0.05). 
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Treatment Group Average Mean Fluorescence Intensity (MFI) 
Untreated 89.45 ± 0.6 
ZNP Only 106 ± 0.0 
ZNP + 200U Catalase 113.5 ± 5.0 
ZNP + 2,000U Catalase 142.5 ± 16.3 
 
Table 5:  Shift in levels of intracellular ROS between treatment groups as 
measured by average mean fluorescence intensity.  
  
 After confirmation that exogenous catalase reduces cell death, its lack of 
inhibition of ZNP-induced intracellular ROS indicates that it does not quench H2O2 
before encountering the cell, but subsequent to the particles’ reaction with the cell.  This 
result suggests that cells release H2O2 as a proapoptotic factor downstream of an initial 
trigger induced directly from the ZNPs.  This signal would then induce surrounding cells 
to undergo apoptosis.  In this scenario, catalase actually blocks the toxic paracrine signal 
from reaching surrounding cells.  This result could also explain why DMPO treatment 
failed to reduce apoptosis, since there is no indication that superoxide radicals would be 
required as an intermediate species if H2O2 is released by the cells. 
 Conversely, if catalase were to inhibit intracellular ROS production, it would 
suggest that it quenches extracellular H2O2 prior to reaching the cell, potentially as a 
product of a ZNP surface reaction. Furthermore, it would indicate that nanotoxicity may 
be independent of cellular uptake, since catalase most likely acts outside the cell.  
Internalization studies show that ZNPs are internalized in phagocytic cell types of the 
immune system.  This may account for the incomplete inhibition of toxicity by catalase.  
Once the cell compartmentalizes the nanoparticles, it isolates them from active catalase 
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diffusing through the extracellular media and becomes vulnerable to surface-produced 
H2O2 from the internalized particles. 
 
 
5. CONCLUSIONS AND FUTURE DIRECTION 
 ZNPs are significantly more toxic to immune cells than titanium dioxide NPs or 
gold NPs of comparable size and concentration.  This indicates that an adverse effect of a 
nanomaterial is not determined solely by its nano size or its ability to enter the cell, but 
also by properties inherent to its composition.  To isolate and test specific points along 
the illusive pathway of ZnO nanotoxicity, several strategies were pursued, including 
inhibition of cellular uptake and extracellular quenching of several factors.   
ZnO nanoparticle PEGylation through hydrogen-bonded surface adsorption was 
deemed to be ineffective in preventing nanoparticle internalization due to its inability to 
resist protein adsorption to the particle surface.  This is likely due to an inadequate 
surface architecture of PEG molecules to endow the nanoparticle periphery with a 
structural water barrier.  Without a hydrophilic barrier, proteins most likely adsorbed to 
the PEG coating directly, marking the nanoparticle for phagocytic uptake.   After 
assessing the inadequacies of an adsorbed PEG coating, it may be advantageous to pursue 
a more complex design.  One promising technique that has been applied to other metal 
oxides such as niobium oxide is the covalent engraftment of PEG molecules to 
intermediate polymers such as poly(ethylene imine) (PEI) (Bergstrand et al 2010) or 
poly(L-lysine) (PLL) (Pasche et al 2003).  These intermediate polymers could then be 
adsorbed to the ZnO nanoparticle surface. 
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The possibility that ZnO nanotoxicity may be reduced with exogenous catalase 
could have important applicability for the engineering of safe zinc oxide 
nanotechnologies.  Recently, 5 nm platinum nanoparticles (PtNPs) have been shown to 
mimic the effects of catalase by quenching hydrogen peroxide in a dose-dependent 
manner (Kajita et al 2007).  Because PtNPs have a low membrane permeability, their 
biomedical applicability as a treatment for oxidative stress diseases is discouraging (Kim 
et al 2010).  However, perhaps their impermeability, paired with their catalase mimetic 
properties, could be useful as in detoxifying ingested ZNPs.  Weak attachment of PtNPs 
to ZNPs may permit photocatalytic or UV-absorptive traits, while allowing dissociation 
of the two species in physiological conditions (i.e. upon inhalation).  Based on the 
indicated role of exogenous catalase in reducing ZNP toxicity, PtNPs may serve as a 
more permanent inhibitor.  
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